Exploiting the antioxidant potential of a common vitamin: Could vitamin C prevent postmenopausal osteoporosis?

Journal of Obstetrics and Gynaecology Research

Volumn 38, Issue 1, 2012, Pages 253-257

  Talaulikar, Vikram Sinai ^a   Chambers, Timothy ^b   Manyonda, Isaac ^a  

^a ST GEORGE'S UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Antioxidants; Menopause; Osteoporosis; Oxidative stress; Vitamin C

Indexed keywords

ASCORBIC ACID;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; BONE METABOLISM; DRUG ABSORPTION; DRUG EXCRETION; FEMALE; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

ANTIOXIDANTS; ASCORBIC ACID; BIOLOGICAL MARKERS; BONE DENSITY; FEMALE; HUMANS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; OXIDATIVE STRESS; PILOT PROJECTS; POSTMENOPAUSE;

EID: 84856249314     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2011.01629.x     Document Type: Article

References (26)

1. Bonomini F, Tengattini S, Fabiano A, Bianchi R, Rezzani R. Atherosclerosis and oxidative stress. Histol Histopathol 2008; 23: 381-390.
2. Praticò D. Evidence of oxidative stress in Alzheimer's disease brain and antioxidant therapy: Lights and shadows. Ann N Y Acad Sci 2008; 1147: 70-78.
3. Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 2006; 160: 1-40. (Pubitemid 43227479)
4. Chappell LC, Seed PT, Kelly FJ et al. Vitamin C and E supplementation in women at risk of preeclampsia is associated with changes in indices of oxidative stress and placental function. Am J Obstet Gynecol 2002; 187: 777-784.
5. Maggio D, Barabani M, Pierandrei M et al. Marked decrease in plasma antioxidants in aged osteoporotic women: Results of a cross-sectional study. J Clin Endocrinol Metab 2003; 88: 1523-1527. (Pubitemid 36623364)
6. Nursing Times.net. Osteoporosis. [Cited 12 Feb 2009.] Available from URL: http://www.nursingtimes.net/whats-newin- nursing/osteoporosis/1989525.article.
7. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288: 321-333.
8. Committee on Safety of Medicines. Further advice on safety of HRT: Risk:benefit unfavourable for first-line use in prevention of osteoporosis. CEM/CMO/2003/19. [Cited 26 Apr 2010.] Available from URL: http://www.mhra.gov.uk
9. Lean JM, Davies JT, Fuller K et al. A crucial role for thiol antioxidants in estrogen-deficiency bone loss. J Clin Invest 2003; 112: 915-923. (Pubitemid 38063749)
10. Cameron E, Campbell A. The orthomolecular treatment of cancer. II. Clinical trial of high-dose ascorbic acid supplements in advanced human cancer. Chem Biol Interact 1974; 9: 285-315.
11. Chappell LC, Seed PT, Briley AL et al. Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: A randomised trial. Lancet 1999; 354: 810-816. (Pubitemid 29415585)
12. Margolis SA, Duewer DL. Measurement of ascorbic acid in human plasma and serum: Stability, intralaboratory repeatability, and interlaboratory reproducibility. Clin Chem 1996; 42 (8 Pt 1): 1257-1262. (Pubitemid 26260347)
13. Institute of Medicine (US), Panel on Dietary Antioxidants and Related Compounds. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids: A Report of the Panel on Dietary Antioxidants and Related Compounds, Subcommittees on Upper Reference Levels of Nutrients and Interpretation and Use of Dietary Reference Intakes, and the Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board, Institute of Medicine. Washington, DC: National Academy Press, 2000.
14. Padayatty SJ, Sun H, Wang Y et al. Vitamin C pharmacokinetics: Implications for oral and intravenous use. Ann Intern Med 2004; 140: 533-537.
15. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994; 330: 1029-1035.
16. Hennekens CH, Buring JE, Manson JE et al. Lack of effect of long term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996; 334: 1145-1149. (Pubitemid 26137972)
17. Omenn GS, Goodman GE, Thornquist MD et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996; 334: 1150-1155. (Pubitemid 26137973)
18. Beazley D, Ahokas R, Livingston J, Griggs M, Sibai BM. Vitamin C and E supplementation in women at high risk for preeclampsia: A double-blind, placebo-controlled trial. Am J Obstet Gynecol 2005; 192: 520-521. (Pubitemid 40214989)
19. Poston L, Briley AL, Seed PT, Kelly FJ, Shennan AH. Vitamins in Pre-eclampsia (VIP) Trial Consortium. Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): Randomised placebo-controlled trial. Lancet 2006; 367: 1145-1154.
20. Spinnato JA 2nd, Freire S, Pinto E Silva JL et al. Antioxidant therapy to prevent preeclampsia: A randomized controlled trial. Obstet Gynecol 2007; 110: 1311-1318. (Pubitemid 351326075)
21. Klemmensen A, Tabor A, Østerdal ML et al. Intake of vitamin C and E in pregnancy and risk of pre-eclampsia: Prospective study among 57 346 women. BJOG 2009; 116: 964-974.
22. Villar J, Purwar M, Merialdi M et al. WHO Vitamin C and Vitamin E trial group.World Health Organisation multicentre randomised trial of supplementation with vitamins C and E among pregnant women at high risk for pre-eclampsia in populations of low nutritional status from developing countries. BJOG 2009; 116: 780-788.
23. Roberts JM, Myatt L, Spong CY et al. Vitamins C and E to prevent complications of pregnancy-associated hypertension. N Engl J Med 2010; 362: 1282-1291.
24. Xu H, Perez-Cuevas R, Xiong X et al. An international trial of antioxidants in the prevention of preeclampsia (INTAPP). Am J Obstet Gynecol 2010; 202: 239.e1-239.e10.
25. Miller ER 3rd, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E. Meta-analysis: High-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 2005; 142: 37-46.
26. Rumbold A, Duley L, Crowther CA, Haslam RR. Antioxidants for preventing pre-eclampsia. Cochrane Database Syst Rev 2008; (1): CD004227.